In-House Counsel
As an in-house counsel in the life sciences industry, staying ahead of evolving intellectual property (IP) and regulatory exclusivity trends is essential to protecting innovation and driving business success. The Life Science Strategy Summit on IP & Exclusivity 2025 offers a unique opportunity for in-house legal professionals to gain exclusive insights from industry leaders, navigate complex patent and regulatory landscapes, and enhance strategic decision-making. With tailored discussions, expert-led panels, and interactive networking sessions, this event is designed to provide in-house counsels with practical tools and critical updates to optimize their company’s IP and exclusivity strategies in an increasingly competitive market.
The Life Science In-house Experience
Your Benefits
- Exclusive Insights from Industry Leaders: Gain firsthand knowledge from top in-house experts from leading pharmaceutical and biotech companies, including Bayer, Novo Nordisk, Sandoz, Amgen, and more. These insights will help shape your corporate understanding of IP and its intersection with prosecution, litigation, regulatory and competition law.
- Strategic Networking Opportunities: Engage in high-level discussions and establish valuable connections with fellow in-house counsels, regulatory specialists, and private practice professionals. The event includes dedicated networking sessions to foster meaningful business relationships.
- Latest Updates on SPCs, PTEs, and Regulatory Exclusivities: Stay ahead of the curve with updates on the latest case law, European SPC reforms, unitary SPC proposals, regulatory and competition law changes which will impact life science exclusivity strategies.
- Practical Discussions on Litigation and Compliance: Benefit from tracked discussions on large molecule and small molecule products, allowing you to craft and understand a more detailed approach towards the IP, regulatory and competition law challenges.
- Customized Roundtable and Interactive Sessions: Participate in expert-led interactive roundtables on key topics such as AI in legal workflows, diversity in IP, licensing strategies, and patentability concerns, allowing for deep engagement and actionable takeaways.
